MindWalk debuts ReefIQ AI drug-discovery platform on AMD Instinct at Advancing AI 2026

MindWalk Holdings Corp.

MindWalk Holdings Corp.

HYFT

0.00
  • MindWalk unveiled the first public demo of its ReefIQ biological context layer for AI drug discovery, running on AMD Instinct at AMD Advancing AI 2026.
  • ReefIQ is positioned as a governed data layer between customer discovery data and AI reasoning workflows, aiming to improve regulated, audit-ready use of AI.
  • MindWalk flagged customer and partner engagement around hosting and governance of regulated biological context; LensAI is already in contracted, recurring customer arrangements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MindWalk Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260723409674) on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.